
JAMA Clinical Reviews
Author interviews that explore the latest clinical reviews.
Latest episodes

Jul 25, 2024 • 16min
Heat-Related Illness and Athletes
Dr. Francis G. O'Connor and Dr. David Simel discuss heat-related illness in athletes, covering risk factors, prevention, symptoms, and management. They explore wet bulb globe temperature, acclimatization techniques, personalized hydration plans, and individualized risk factors in preventing exertional heat illness.

13 snips
Jul 22, 2024 • 18min
Obesity Medications
Dr. Robert F. Kushner from Northwestern University discusses new weight-loss drugs for obesity management. Topics include nutrient-stimulated hormone-based meds, less common medications, comparing terzepatide to semaglutide, and future weight loss drug advancements. The focus is on improving overall health outcomes with successful interventions.

Jul 17, 2024 • 13min
Medical Practice and Climate Change
Medical practice accounts for 8% of carbon emissions in the US. Author Wendy Levinson, MD, discusses simple changes that clinicians can make to reduce adverse effects of health care on the climate and the environment with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Medical Practice and the Climate Crisis How Can Operating Rooms Be Greener?

Jul 8, 2024 • 21min
Essential Tremor
Dr. Binit B. Shah discusses diagnosing and treating essential tremor with Dr. Christopher C. Muth. They cover non-pharmacological, pharmacological, and surgical treatments, including deep brain stimulation and MRI guided focused ultrasound thalamotomy.

Jul 1, 2024 • 16min
Why Should Insurers Care About Clinical Trials?
The US is a global leader in introducing new medical products, but the ability to generate evidence to inform clinical practice in postmarket settings must improve. Insurers may have an important role to play. Robert M. Califf, MD, of the US Food and Drug Administration, discusses why and how payers could support evidence generation with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Why Evidence Generation Should Matter to Payers and How They Can Help

Jun 26, 2024 • 18min
Update: Diagnosis and Management of Celiac Disease
What are the common signs and symptoms of celiac disease and how is this disease diagnosed and managed? Author Kerstin Austin, MD, from the University of Wisconsin-Madison, discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS. Related Content: Diagnosis and Management of Celiac Disease

Jun 26, 2024 • 13min
Hospital Gun Restrictions
Hospitals are on the frontlines of the US gun violence epidemic, both through the treatment of shooting victims and as sites of firearm violence. At least 240 shootings occurred on US hospital grounds from 2000 to 2016 alone. Author Joseph Blocher, MPhil, JD, from Duke Law School talks about this and more with JAMA Network Open Editor in Chief Frederick P. Rivara, MD, MPH. Related Content: Firearm Policy in the Hospital Setting—Recognizing Health Care as a “Sensitive Place” State Approaches to Stopping Violence Against Health Care Workers

Jun 18, 2024 • 13min
USPSTF Recommendation: Interventions for High BMI in Children and Adolescents
Interview with John M. Ruiz, PhD, USPSTF member and coauthor of Management of BMI in Children: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Interventions for Weight Management in Children and Adolescents Interventions for High Body Mass Index in Children and Adolescents Interventions for High BMI in Children and Teenagers Treatment Interventions for Child and Adolescent Obesity

Jun 12, 2024 • 17min
Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections
Expert in critical care medicine, Romain Pirracchio, discusses the benefits of using low-dose corticosteroids in treating severe pulmonary infections. Topics include the use of corticosteroids in COVID-19 cases, positive impacts on mortality in Community-Acquired Pneumonia, and guidelines for timely initiation of treatment in critically ill patients.

Jun 10, 2024 • 16min
Managing Depression in Adults
Approximately 9% of US adults experience major depression each year, with lifetime prevalence nearly 17% for men and 30% for women. Effective first-line depression treatments include forms of psychotherapy and medication. Close monitoring significantly improves likelihood of treatment success. Gregory E. Simon, MD, MPH, discusses depression treatment with JAMA Senior Editor Karen E. Lasser, MD, MPH. Related Content: Management of Depression in Adults